Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GET MORE AI-GENERATED SIGNALS: September 19, 2024, 20:16 pm ET, BY Jeff W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

Rise and shine, everyone, another busy day is on the way. However, this is shaping up as a beautiful day as well, despite forecasts suggesting a cloud or two will later hover about. Right now, the ...

GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...

High response rates reported by GSK and iTeos at the 2024 European Society for Medical Oncology Congress offer a ray of light ...

Shares of GSK PLC GSK inched up 0.73% to £16.64 Monday, on what proved to be an all-around great trading session for the ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), ...

The revenue for GSK-3739937 is expected to reach an annual total of $7 mn by 2037 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to ...

PITTSBURGH – The Nationals got the job done in Game 1 of today’s doubleheader against the Pirates. DJ Herz tossed five no-hit innings before departing with his pitch count at 87. Dylan Crews ...

Proactive Investors - GSK PLC (LON:GSK) announced positive results from a Phase III clinical trial, MATINEE, evaluating Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD). The trial ...